How Chicago Is Becoming The Frontline Of Innovation [Forbes]
Twist Bioscience Corporation (TWST)
Last twist bioscience corporation earnings: 2/6 04:05 pm
Check Earnings Report
Company Research
Source: Forbes
mHUB mobilizes to produce PPE for frontline health care workersFrom giving back to the community and supporting frontline health care workers to coming up with novel medical solutions and more, Chicago-based companies have not stepped down in the fight against COVID-19. Rather they are using it as an opportunity to innovate, collaborate, and evolve. Now in mythird article of this series, find the latest updates below from the Windy City’s frontline of innovation.ARCH Venture Partners:Chicago-based firm Arch Ventures recently raised $1.46 billion in funding to invest in early-stage biotech companies. The firm already backs a handful of companies working on COVID-19 therapeutics, including Twist Bioscience, a developer of gene engineering tools used in COVID therapeutics and vaccine development.Catalytic:Automation technology provider Catalytic is helping companies assess risk and develop emergency response plans to the virus. Companies that have successfully used the technology include
Show less
Read more
Impact Snapshot
Event Time:
TWST
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TWST alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TWST alerts
High impacting Twist Bioscience Corporation news events
Weekly update
A roundup of the hottest topics
TWST
News
- Twist Bioscience (TWST): Valuation Check After New Research-Grade Plasmid DNA Preps Boost Investor Interest [Yahoo! Finance]Yahoo! Finance
- Twist Bioscience Launches New Plasmid Preps to Enable Nucleic Acid Therapeutics ResearchBusiness Wire
- Kuehn Law Encourages Investors of Twist Bioscience Corporation to Contact Law FirmGlobeNewswire
- Twist Bioscience (NASDAQ:TWST) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Stephens Initiates Twist Bioscience (TWST) With Overweight Rating, Sets $41 PT [Yahoo! Finance]Yahoo! Finance
TWST
Earnings
- 11/14/25 - Miss
TWST
Sec Filings
- 11/25/25 - Form 4
- 11/25/25 - Form 4
- 11/25/25 - Form 4
- TWST's page on the SEC website